Protein C in critical illness

被引:16
作者
Mann, Henry J. [1 ,2 ]
Short, Mary A.
Schlichting, Douglas E. [3 ]
机构
[1] Univ Minnesota, Coll Pharm, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Ctr Excellence Crit Care, Minneapolis, MN 55455 USA
[3] Eli Lilly & Co, Acute Care Div, Indianapolis, IN 46285 USA
关键词
Critical illness; Homeostasis; Mortality; Polymorphism; Protein C; Sepsis; ORGAN DYSFUNCTION SYNDROME; SEVERE SEPSIS; SEPTIC SHOCK; PLASMA; DEATH; RISK; SAFETY;
D O I
10.2146/ajhp080276
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Purpose. The role of protein C in critical illness is assessed. Summary. Conversion of protein C to activated protein C (APC) requires thrombin and thrombomodulin. When thrombin is not bound to thrombomodulin, it can convert fibrinogen to fibrin, factor V to factor Va, and factor VIII to factor VIIIa but will not convert protein C to APC. When thrombin is bound to thrombomodulin, it can convert protein C to APC but cannot convert fibrinogen, factor V, or factor VIII. Activation of protein C is accelerated by the presence of endothelial protein C receptors. In conjunction with protein S, APC limits coagulation by inactivating factors Va and VIIIa, which decreases thrombin-mediated inflammation. By inhibiting the formation of thrombin and the release of proinflammatory cytokines, APC.reduces the inflammatory response to infection. By inducing cell signaling, APC directly modulates the cellular response to infection, resulting in antiinflammatory, cytoprotective, and barrier-protective activities. APC is metabolized by protease inhibitors and other proteins in the plasma. Conversion of protein C to APC is impaired in severe sepsis. During severe sepsis, endogenous levels of the inactive precursor protein C are reduced because of decreased production by the liver and degradation by enzymes. More than 85% of patients with severe sepsis have low levels of protein C. Absolute levels of protein C correlate with morbidity and mortality outcomes of the sepsis population, regardless of age, infecting microorganism, presence of shock, disseminated intravascular coagulation, degree of hypercoagulation, or severity of illness. Conclusion. The protein C pathway is a natural homeostatic regulator with multiple mechanisms of action. Blood protein C concentration is inversely correlated with morbidity and mortality in sepsis and other critical illness.
引用
收藏
页码:1089 / 1096
页数:8
相关论文
共 39 条
[1]
Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death [J].
Abraham, E ;
Laterre, P ;
Garg, R ;
Levy, H ;
Talwar, D ;
Trzaskoma, BL ;
Francois, B ;
Guy, JS ;
Bruckmann, M ;
Rea-Neto, A ;
Rossaint, R ;
Perrotin, D ;
Sablotzki, A ;
Arkins, N ;
Utterback, BG ;
Macias, WL .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) :1332-1341
[2]
The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome [J].
Aird, WC .
BLOOD, 2003, 101 (10) :3765-3777
[3]
The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent [J].
Bajzar, L ;
Nesheim, ME ;
Tracy, PB .
BLOOD, 1996, 88 (06) :2093-2100
[4]
AGING-ASSOCIATED CHANGES IN INDEXES OF THROMBIN GENERATION AND PROTEIN-C ACTIVATION IN HUMANS - NORMATIVE AGING STUDY [J].
BAUER, KA ;
WEISS, LM ;
SPARROW, D ;
VOKONAS, PS ;
ROSENBERG, RD .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (06) :1527-1534
[5]
Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[6]
Changes of the hemostatic network in critically ill patients - Is there a difference between sepsis, trauma, and neurosurgery patients? [J].
Boldt, J ;
Papsdorf, M ;
Rothe, A ;
Kumle, B ;
Piper, S .
CRITICAL CARE MEDICINE, 2000, 28 (02) :445-450
[7]
Protein C concentrations correlate with organ dysfunction and predict outcome independent of the presence of sepsis [J].
Brunkhorst, Frank ;
Sakr, Yasser ;
Hagel, Stefan ;
Reinhart, Konrad .
ANESTHESIOLOGY, 2007, 107 (01) :15-23
[8]
A systematic review of the quality of genetic association studies in human sepsis [J].
Clark, Martin Fraser ;
Baudouin, SimonVictor .
INTENSIVE CARE MEDICINE, 2006, 32 (11) :1706-1712
[9]
Genetics of susceptibility to human infectious disease [J].
Cooke, GS ;
Hill, AVS .
NATURE REVIEWS GENETICS, 2001, 2 (12) :967-977
[10]
Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host coagulopathy response in patients with severe sepsis [J].
Dhainaut, JFO ;
Yan, SB ;
Margolis, BD ;
Lorente, JA ;
Russell, JA ;
Freebairn, RC ;
Spapen, HD ;
Riess, H ;
Basson, B ;
Johnson, G ;
Kinasewitz, GT .
THROMBOSIS AND HAEMOSTASIS, 2003, 90 (04) :642-653